Association between inflammatory bowel disease, nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease: A propensity score‐matched analysis of US nationwide inpatient sample 2016–2018
Objectives The incidence and prevalence of inflammatory bowel disease (IBD), mainly including ulcerative colitis (UC) and Crohn's disease (CD), are increasing globally. We aimed to evaluate the potential association between IBD and nephrolithiasis, tubulointerstitial nephritis, and chronic kidn...
        Saved in:
      
    
          | Published in | Journal of digestive diseases Vol. 24; no. 11; pp. 572 - 583 | 
|---|---|
| Main Authors | , , , , , , | 
| Format | Journal Article | 
| Language | English | 
| Published | 
        Melbourne
          Wiley Publishing Asia Pty Ltd
    
        01.11.2023
     Wiley Subscription Services, Inc  | 
| Subjects | |
| Online Access | Get full text | 
| ISSN | 1751-2972 1751-2980 1751-2980  | 
| DOI | 10.1111/1751-2980.13233 | 
Cover
| Abstract | Objectives
The incidence and prevalence of inflammatory bowel disease (IBD), mainly including ulcerative colitis (UC) and Crohn's disease (CD), are increasing globally. We aimed to evaluate the potential association between IBD and nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease (CKD).
Methods
Data of hospitalized adults ≥20 years of age were extracted from the U.S. National Inpatient Sample (NIS) during 2016–2018. Patients with UC, CD, or CKD were identified through the International Classification of Diseases, Tenth Revision (ICD‐10) codes. Propensity score matching (PSM) analysis (1:1) was conducted to balance the characteristics between groups. Logistic regression analyses were performed to determine the relationships between UC or CD and kidney conditions.
Results
Three cohorts were included for analysis after PSM analysis. Cohorts 1, 2 and 3 contained 235 262 subjects (117 631 with CD or without IBD), 140 856 subjects (70 428 with UC or without IBD), and 139 098 subjects (69 549 with CD or UC), respectively. Multivariate analysis revealed that compared to non‐IBD individuals, CD patients were significantly associated with greater odds for nephrolithiasis (adjusted odds ratio [aOR] 2.25, 95% confidence interval [CI] 2.08–2.43), tubulointerstitial nephritis (aOR 1.31, 95% CI 1.24–1.38), CKD at any stage (aOR 1.28, 95% CI 1.24–1.32), and moderate‐to‐severe CKD (aOR 1.22, 95% CI 1.17–1.26), while UC was associated with a higher rate of nephrolithiasis. Compared to UC, CD was associated with higher odds for all such kidney conditions.
Conclusions
Patients with CD are more likely to have nephrolithiasis, tubulointerstitial nephritis, CKD at any stage, and moderate‐to‐severe CKD compared to non‐IBD individuals.
We assessed the relationship between inflammatory bowel disease (IBD), nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease (CKD) using a large, nationally representative U.S. database. This extensive epidemiological study indicates that individuals with Crohn's disease (CD) are particularly prone to having nephrolithiasis, tubulointerstitial nephritis, CKD at any stage, and moderate‐to‐severe CKD. | 
    
|---|---|
| AbstractList | ObjectivesThe incidence and prevalence of inflammatory bowel disease (IBD), mainly including ulcerative colitis (UC) and Crohn's disease (CD), are increasing globally. We aimed to evaluate the potential association between IBD and nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease (CKD).MethodsData of hospitalized adults ≥20 years of age were extracted from the U.S. National Inpatient Sample (NIS) during 2016–2018. Patients with UC, CD, or CKD were identified through the International Classification of Diseases, Tenth Revision (ICD‐10) codes. Propensity score matching (PSM) analysis (1:1) was conducted to balance the characteristics between groups. Logistic regression analyses were performed to determine the relationships between UC or CD and kidney conditions.ResultsThree cohorts were included for analysis after PSM analysis. Cohorts 1, 2 and 3 contained 235 262 subjects (117 631 with CD or without IBD), 140 856 subjects (70 428 with UC or without IBD), and 139 098 subjects (69 549 with CD or UC), respectively. Multivariate analysis revealed that compared to non‐IBD individuals, CD patients were significantly associated with greater odds for nephrolithiasis (adjusted odds ratio [aOR] 2.25, 95% confidence interval [CI] 2.08–2.43), tubulointerstitial nephritis (aOR 1.31, 95% CI 1.24–1.38), CKD at any stage (aOR 1.28, 95% CI 1.24–1.32), and moderate‐to‐severe CKD (aOR 1.22, 95% CI 1.17–1.26), while UC was associated with a higher rate of nephrolithiasis. Compared to UC, CD was associated with higher odds for all such kidney conditions.ConclusionsPatients with CD are more likely to have nephrolithiasis, tubulointerstitial nephritis, CKD at any stage, and moderate‐to‐severe CKD compared to non‐IBD individuals. Objectives The incidence and prevalence of inflammatory bowel disease (IBD), mainly including ulcerative colitis (UC) and Crohn's disease (CD), are increasing globally. We aimed to evaluate the potential association between IBD and nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease (CKD). Methods Data of hospitalized adults ≥20 years of age were extracted from the U.S. National Inpatient Sample (NIS) during 2016–2018. Patients with UC, CD, or CKD were identified through the International Classification of Diseases, Tenth Revision (ICD‐10) codes. Propensity score matching (PSM) analysis (1:1) was conducted to balance the characteristics between groups. Logistic regression analyses were performed to determine the relationships between UC or CD and kidney conditions. Results Three cohorts were included for analysis after PSM analysis. Cohorts 1, 2 and 3 contained 235 262 subjects (117 631 with CD or without IBD), 140 856 subjects (70 428 with UC or without IBD), and 139 098 subjects (69 549 with CD or UC), respectively. Multivariate analysis revealed that compared to non‐IBD individuals, CD patients were significantly associated with greater odds for nephrolithiasis (adjusted odds ratio [aOR] 2.25, 95% confidence interval [CI] 2.08–2.43), tubulointerstitial nephritis (aOR 1.31, 95% CI 1.24–1.38), CKD at any stage (aOR 1.28, 95% CI 1.24–1.32), and moderate‐to‐severe CKD (aOR 1.22, 95% CI 1.17–1.26), while UC was associated with a higher rate of nephrolithiasis. Compared to UC, CD was associated with higher odds for all such kidney conditions. Conclusions Patients with CD are more likely to have nephrolithiasis, tubulointerstitial nephritis, CKD at any stage, and moderate‐to‐severe CKD compared to non‐IBD individuals. We assessed the relationship between inflammatory bowel disease (IBD), nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease (CKD) using a large, nationally representative U.S. database. This extensive epidemiological study indicates that individuals with Crohn's disease (CD) are particularly prone to having nephrolithiasis, tubulointerstitial nephritis, CKD at any stage, and moderate‐to‐severe CKD. The incidence and prevalence of inflammatory bowel disease (IBD), mainly including ulcerative colitis (UC) and Crohn's disease (CD), are increasing globally. We aimed to evaluate the potential association between IBD and nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease (CKD).OBJECTIVESThe incidence and prevalence of inflammatory bowel disease (IBD), mainly including ulcerative colitis (UC) and Crohn's disease (CD), are increasing globally. We aimed to evaluate the potential association between IBD and nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease (CKD).Data of hospitalized adults ≥20 years of age were extracted from the U.S. National Inpatient Sample (NIS) during 2016-2018. Patients with UC, CD, or CKD were identified through the International Classification of Diseases, Tenth Revision (ICD-10) codes. Propensity score matching (PSM) analysis (1:1) was conducted to balance the characteristics between groups. Logistic regression analyses were performed to determine the relationships between UC or CD and kidney conditions.METHODSData of hospitalized adults ≥20 years of age were extracted from the U.S. National Inpatient Sample (NIS) during 2016-2018. Patients with UC, CD, or CKD were identified through the International Classification of Diseases, Tenth Revision (ICD-10) codes. Propensity score matching (PSM) analysis (1:1) was conducted to balance the characteristics between groups. Logistic regression analyses were performed to determine the relationships between UC or CD and kidney conditions.Three cohorts were included for analysis after PSM analysis. Cohorts 1, 2 and 3 contained 235 262 subjects (117 631 with CD or without IBD), 140 856 subjects (70 428 with UC or without IBD), and 139 098 subjects (69 549 with CD or UC), respectively. Multivariate analysis revealed that compared to non-IBD individuals, CD patients were significantly associated with greater odds for nephrolithiasis (adjusted odds ratio [aOR] 2.25, 95% confidence interval [CI] 2.08-2.43), tubulointerstitial nephritis (aOR 1.31, 95% CI 1.24-1.38), CKD at any stage (aOR 1.28, 95% CI 1.24-1.32), and moderate-to-severe CKD (aOR 1.22, 95% CI 1.17-1.26), while UC was associated with a higher rate of nephrolithiasis. Compared to UC, CD was associated with higher odds for all such kidney conditions.RESULTSThree cohorts were included for analysis after PSM analysis. Cohorts 1, 2 and 3 contained 235 262 subjects (117 631 with CD or without IBD), 140 856 subjects (70 428 with UC or without IBD), and 139 098 subjects (69 549 with CD or UC), respectively. Multivariate analysis revealed that compared to non-IBD individuals, CD patients were significantly associated with greater odds for nephrolithiasis (adjusted odds ratio [aOR] 2.25, 95% confidence interval [CI] 2.08-2.43), tubulointerstitial nephritis (aOR 1.31, 95% CI 1.24-1.38), CKD at any stage (aOR 1.28, 95% CI 1.24-1.32), and moderate-to-severe CKD (aOR 1.22, 95% CI 1.17-1.26), while UC was associated with a higher rate of nephrolithiasis. Compared to UC, CD was associated with higher odds for all such kidney conditions.Patients with CD are more likely to have nephrolithiasis, tubulointerstitial nephritis, CKD at any stage, and moderate-to-severe CKD compared to non-IBD individuals.CONCLUSIONSPatients with CD are more likely to have nephrolithiasis, tubulointerstitial nephritis, CKD at any stage, and moderate-to-severe CKD compared to non-IBD individuals. The incidence and prevalence of inflammatory bowel disease (IBD), mainly including ulcerative colitis (UC) and Crohn's disease (CD), are increasing globally. We aimed to evaluate the potential association between IBD and nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease (CKD). Data of hospitalized adults ≥20 years of age were extracted from the U.S. National Inpatient Sample (NIS) during 2016-2018. Patients with UC, CD, or CKD were identified through the International Classification of Diseases, Tenth Revision (ICD-10) codes. Propensity score matching (PSM) analysis (1:1) was conducted to balance the characteristics between groups. Logistic regression analyses were performed to determine the relationships between UC or CD and kidney conditions. Three cohorts were included for analysis after PSM analysis. Cohorts 1, 2 and 3 contained 235 262 subjects (117 631 with CD or without IBD), 140 856 subjects (70 428 with UC or without IBD), and 139 098 subjects (69 549 with CD or UC), respectively. Multivariate analysis revealed that compared to non-IBD individuals, CD patients were significantly associated with greater odds for nephrolithiasis (adjusted odds ratio [aOR] 2.25, 95% confidence interval [CI] 2.08-2.43), tubulointerstitial nephritis (aOR 1.31, 95% CI 1.24-1.38), CKD at any stage (aOR 1.28, 95% CI 1.24-1.32), and moderate-to-severe CKD (aOR 1.22, 95% CI 1.17-1.26), while UC was associated with a higher rate of nephrolithiasis. Compared to UC, CD was associated with higher odds for all such kidney conditions. Patients with CD are more likely to have nephrolithiasis, tubulointerstitial nephritis, CKD at any stage, and moderate-to-severe CKD compared to non-IBD individuals.  | 
    
| Author | Zheng, Wei Wei Zhou, Quan Ao, Lu Chen, Jin Tong Yu, Xing Wang, Cheng Dang Xue, Meng Li  | 
    
| Author_xml | – sequence: 1 givenname: Wei Wei orcidid: 0000-0002-9188-319X surname: Zheng fullname: Zheng, Wei Wei organization: Clinical Research Center for Liver and Intestinal Diseases of Fujian Province – sequence: 2 givenname: Quan surname: Zhou fullname: Zhou, Quan organization: Fuzhou Center for Disease Control and Prevention Affiliated to Fujian Medical University – sequence: 3 givenname: Meng Li surname: Xue fullname: Xue, Meng Li organization: Clinical Research Center for Liver and Intestinal Diseases of Fujian Province – sequence: 4 givenname: Xing surname: Yu fullname: Yu, Xing organization: Clinical Research Center for Liver and Intestinal Diseases of Fujian Province – sequence: 5 givenname: Jin Tong surname: Chen fullname: Chen, Jin Tong organization: Clinical Research Center for Liver and Intestinal Diseases of Fujian Province – sequence: 6 givenname: Lu surname: Ao fullname: Ao, Lu organization: Fujian Key Laboratory of Medical Bioinformatics, School of Medical Technology and Engineering, Fujian Medical University – sequence: 7 givenname: Cheng Dang orcidid: 0000-0002-8765-7528 surname: Wang fullname: Wang, Cheng Dang email: wangcdhl@fjmu.edu.cn organization: Clinical Research Center for Liver and Intestinal Diseases of Fujian Province  | 
    
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37823607$$D View this record in MEDLINE/PubMed | 
    
| BookMark | eNqFUstu3CAURVWq5tGuu6uQuski0xiYAbu70SR9SJG6aLNGGF9rSDG4gDXyLp9Qqf-Vj8iXFM8ji0hV2dx74ZxzX5yiI-cdIPSWFB9IPpdELMiMVmUOGWXsBTp5ujl68gU9Rqcx3hXFgouSv0LHTJSU8UKcoIdljF4blYx3uIa0AXDYuNaqrlPJhxHXfgMWNyaCinCBHfTr4K1Ja6OiiRc4DfVgvXEJQkwmGWV3mOzmV-UarDPBGY1_msbBeJD6iJe4D74HF00acdQ-wOP975xVr6HJRGXHnAD7Ft9-x25b4cY0kKvrcwAu4ai63gKmBeGP93-yKV-jl62yEd7s7Rm6_XT9Y_VldvPt89fV8mammSBsVrGGkUIorhZ1PaelglZwzlhb0TmZK9VCuZiLumG04byuKipUlWfKOBO6BKDsDJ3vdHMHvwaISXYmarBWOfBDlLSc9MqKkQx9_wx654eQu8uoqqCCU0EnwXd71FB30Mg-mE6FUR42lQGLHUAHH2OAVmqTtkNJQRkrSSGnHyGnnctp_3L7IzLv8hnvIP1vxj7TxlgY_weXq6urHe8v-1_K5A | 
    
| CitedBy_id | crossref_primary_10_1080_15360288_2025_2481186 | 
    
| Cites_doi | 10.3748/wjg.v20.i1.91 10.1371/journal.pone.0158765 10.1159/000188024 10.1007/978-981-13-8871-2_1 10.1093/ecco-jcc/jjv138 10.1016/j.cgh.2019.10.043 10.3389/fimmu.2019.00815 10.1053/j.ackd.2014.07.002 10.1016/j.pop.2020.08.001 10.1016/0895-4356(93)90103-8 10.3748/wjg.v24.i42.4798 10.1080/15548627.2019.1635384 10.1136/bmj.301.6755.818-b 10.1136/gut.40.6.761 10.1542/pir.2015-0110 10.1038/nrgastro.2015.150 10.2147/IJNRD.S45466 10.12659/MSM.936497 10.1093/gastro/gow015 10.1038/ki.2015.321 10.1016/j.pmedr.2023.102173 10.25122/jml-2018-0075 10.1038/s41581-018-0018-2 10.3390/nu12040944 10.1007/s00535-022-01903-6 10.1136/bmj.296.6634.1442 10.1007/s40257-022-00689-w 10.1371/journal.pone.0115947 10.1186/s12882‐021‐02358‐2 10.1023/A:1026629528233 10.1136/gut.38.1.99 10.1186/s40001‐022‐00687‐y 10.1136/bmj.e5287 10.1016/0016-5085(94)90066-3 10.1111/jgh.14356 10.1590/1806-9282.66.s1.3 10.15171/jnp.2017.42 10.2215/CJN.04660513 10.1046/j.1523-1755.2003.00725.x 10.1016/S0140-6736(17)32448-0 10.1136/gut.33.7.1006 10.1016/j.nefro.2016.05.008 10.1038/nrgastro.2017.88 10.1097/MIB.0000000000000963 10.1002/hsr2.1563 10.1093/ibd/izac140 10.1097/00005792-199209000-00001 10.1016/j.amjcard.2015.01.529 10.1001/jamacardio.2016.5131 10.1016/0016-5085(90)90839-S 10.1097/00004836-199701000-00008 10.3389/fcimb.2019.00206 10.1007/s10238-021-00766-0 10.1111/apt.15687 10.3390/ijerph19137933 10.1111/j.1365-2036.2006.03069.x 10.1007/s11255-020-02649-x 10.1136/gut.35.10.1493  | 
    
| ContentType | Journal Article | 
    
| Copyright | 2023 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd. | 
    
| Copyright_xml | – notice: 2023 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd. | 
    
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7X8  | 
    
| DOI | 10.1111/1751-2980.13233 | 
    
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic  | 
    
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts MEDLINE - Academic  | 
    
| DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE - Academic MEDLINE  | 
    
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database  | 
    
| DeliveryMethod | fulltext_linktorsrc | 
    
| Discipline | Medicine | 
    
| EISSN | 1751-2980 | 
    
| EndPage | 583 | 
    
| ExternalDocumentID | 37823607 10_1111_1751_2980_13233 CDD13233  | 
    
| Genre | researchArticle Journal Article  | 
    
| GeographicLocations | United States--US | 
    
| GeographicLocations_xml | – name: United States--US | 
    
| GrantInformation_xml | – fundername: Open Project of Key Laboratories of Medical Bioinformatics in Colleges and Universities in Fujian Province funderid: FKLMB‐2020003 – fundername: 2021 Joint Funds for the Innovation of Science and Technology, Fujian Province funderid: 2021Y9119 – fundername: 2021 Joint Funds for the Innovation of Science and Technology, Fujian Province grantid: 2021Y9119 – fundername: Open Project of Key Laboratories of Medical Bioinformatics in Colleges and Universities in Fujian Province grantid: FKLMB-2020003  | 
    
| GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1OC 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM EAD EAP EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K ROL RX1 SUPJJ SV3 TEORI TUS UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR XG1 ~IA ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7X8  | 
    
| ID | FETCH-LOGICAL-c3713-93d3107a6a5bb428aef76633f92414aafe8547bd32d66b9927a92983637c8ee23 | 
    
| IEDL.DBID | DR2 | 
    
| ISSN | 1751-2972 1751-2980  | 
    
| IngestDate | Thu Jul 10 21:34:17 EDT 2025 Tue Oct 07 06:35:59 EDT 2025 Mon Jul 21 06:06:34 EDT 2025 Wed Oct 01 02:02:55 EDT 2025 Thu Apr 24 22:50:04 EDT 2025 Wed Jan 22 16:15:44 EST 2025  | 
    
| IsPeerReviewed | true | 
    
| IsScholarly | true | 
    
| Issue | 11 | 
    
| Keywords | chronic kidney diseases Crohn disease ulcerative colitis inflammatory bowel diseases  | 
    
| Language | English | 
    
| License | 2023 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd. | 
    
| LinkModel | DirectLink | 
    
| MergedId | FETCHMERGED-LOGICAL-c3713-93d3107a6a5bb428aef76633f92414aafe8547bd32d66b9927a92983637c8ee23 | 
    
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23  | 
    
| ORCID | 0000-0002-8765-7528 0000-0002-9188-319X  | 
    
| PMID | 37823607 | 
    
| PQID | 2902762722 | 
    
| PQPubID | 2034585 | 
    
| PageCount | 12 | 
    
| ParticipantIDs | proquest_miscellaneous_2876638931 proquest_journals_2902762722 pubmed_primary_37823607 crossref_citationtrail_10_1111_1751_2980_13233 crossref_primary_10_1111_1751_2980_13233 wiley_primary_10_1111_1751_2980_13233_CDD13233  | 
    
| ProviderPackageCode | CITATION AAYXX  | 
    
| PublicationCentury | 2000 | 
    
| PublicationDate | November 2023 2023-11-00 2023-Nov 20231101  | 
    
| PublicationDateYYYYMMDD | 2023-11-01 | 
    
| PublicationDate_xml | – month: 11 year: 2023 text: November 2023  | 
    
| PublicationDecade | 2020 | 
    
| PublicationPlace | Melbourne | 
    
| PublicationPlace_xml | – name: Melbourne – name: Australia – name: Richmond  | 
    
| PublicationTitle | Journal of digestive diseases | 
    
| PublicationTitleAlternate | J Dig Dis | 
    
| PublicationYear | 2023 | 
    
| Publisher | Wiley Publishing Asia Pty Ltd Wiley Subscription Services, Inc  | 
    
| Publisher_xml | – name: Wiley Publishing Asia Pty Ltd – name: Wiley Subscription Services, Inc  | 
    
| References | 2017; 5 2017; 6 2002; 15 1990; 98 1997; 40 2017; 2 2023; 33 1990; 301 2021; 22 2023; 6 2019; 10 2019; 12 1994; 67 2022; 23 2017; 390 2020; 16 1999; 44 2020; 12 2021; 72 1996; 38 2016; 37 2019; 1165 2013; 6 2022; 27 2022; 28 2014; 20 2020; 18 2018; 3 2017; 37 2023; 29 2006; 24 2020; 51 2020; 47 1994; 35 1988; 296 2014; 9 1994; 107 1996; 8 2016; 89 2015; 12 1993; 46 2019; 9 2019; 34 1997; 24 2015; 10 2016; 10 2012; 345 1992; 33 1992; 71 2016; 11 2018; 24 2021; 53 2015; 115 2017; 14 2005; 125 2015; 22 2022; 57 2020; 66 2003; 63 2018; 14 2022; 19 2016; 22 e_1_2_9_31_1 e_1_2_9_52_1 e_1_2_9_10_1 e_1_2_9_35_1 e_1_2_9_56_1 e_1_2_9_12_1 e_1_2_9_33_1 e_1_2_9_14_1 e_1_2_9_39_1 e_1_2_9_16_1 e_1_2_9_37_1 e_1_2_9_58_1 e_1_2_9_18_1 Kreisel W (e_1_2_9_29_1) 1996; 8 e_1_2_9_41_1 e_1_2_9_64_1 e_1_2_9_20_1 e_1_2_9_62_1 e_1_2_9_22_1 e_1_2_9_45_1 e_1_2_9_24_1 e_1_2_9_8_1 e_1_2_9_6_1 e_1_2_9_4_1 e_1_2_9_60_1 e_1_2_9_2_1 e_1_2_9_26_1 e_1_2_9_49_1 Ferreira SDC (e_1_2_9_54_1) 2018; 3 e_1_2_9_28_1 e_1_2_9_47_1 Mendoza JL (e_1_2_9_50_1) 2005; 125 e_1_2_9_30_1 e_1_2_9_53_1 e_1_2_9_51_1 e_1_2_9_11_1 e_1_2_9_34_1 e_1_2_9_57_1 e_1_2_9_13_1 e_1_2_9_32_1 e_1_2_9_55_1 e_1_2_9_15_1 e_1_2_9_38_1 e_1_2_9_17_1 e_1_2_9_36_1 e_1_2_9_59_1 e_1_2_9_19_1 e_1_2_9_42_1 e_1_2_9_63_1 e_1_2_9_40_1 e_1_2_9_61_1 e_1_2_9_46_1 e_1_2_9_23_1 e_1_2_9_44_1 e_1_2_9_7_1 e_1_2_9_5_1 Katsanos KT (e_1_2_9_21_1) 2002; 15 e_1_2_9_3_1 e_1_2_9_9_1 Adamowicz M (e_1_2_9_43_1) 2021; 72 e_1_2_9_25_1 e_1_2_9_27_1 e_1_2_9_48_1  | 
    
| References_xml | – volume: 46 start-page: 1075 issue: 10 year: 1993 end-page: 1079 article-title: Adapting a clinical comorbidity index for use with ICD‐9‐CM administrative data: differing perspectives publication-title: J Clin Epidemiol – volume: 98 start-page: 464 issue: 2 year: 1990 end-page: 469 article-title: A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody publication-title: Gastroenterology – volume: 6 start-page: 139 year: 2013 end-page: 142 article-title: Nephrolithiasis in patients with inflammatory bowel disease in the community publication-title: Int J Nephrol Renovasc Dis – volume: 35 start-page: 1493 issue: 10 year: 1994 end-page: 1496 article-title: Mesalazine induced interstitial nephritis publication-title: Gut – volume: 24 start-page: 4798 issue: 42 year: 2018 end-page: 4808 article-title: Increased end‐stage renal disease risk in patients with inflammatory bowel disease: a nationwide population‐based study publication-title: World J Gastroenterol – volume: 29 start-page: 1306 issue: 8 year: 2023 end-page: 1316 article-title: Renal and urological disorders associated with inflammatory bowel disease publication-title: Inflamm Bowel Dis – volume: 5 start-page: 36 issue: 1 year: 2017 end-page: 42 article-title: Nationwide trends of hospital admissions for acute cholecystitis in the United States publication-title: Gastroenterol Rep (Oxf). – volume: 51 start-page: 870 issue: 9 year: 2020 end-page: 879 article-title: Tacrolimus induces short‐term but not long‐term clinical response in inflammatory bowel disease publication-title: Aliment Pharmacol Ther – volume: 22 start-page: 629 issue: 4 year: 2021 end-page: 635 article-title: Spectrum and prognosis of renal histopathological lesions in patients with inflammatory bowel disease: a cross‐sectional study from a single center in China publication-title: Clin Exp Med – volume: 2 start-page: 250 issue: 3 year: 2017 end-page: 258 article-title: Management and outcomes of ST‐segment elevation myocardial infarction in US renal transplant recipients publication-title: JAMA Cardiol – volume: 6 issue: 9 year: 2023 article-title: Joint modeling on serum creatinine and time to end stage of renal disease for chronic kidney disease patients under treatment at the University of Gondar Referral Hospital publication-title: Health Sci Rep. – volume: 8 start-page: 461 issue: 5 year: 1996 end-page: 468 article-title: Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease publication-title: Eur J Gastroenterol Hepatol – volume: 19 start-page: 7933 issue: 13 year: 2022 article-title: Validity of diagnostic algorithms for inflammatory bowel disease in Japanese hospital claims data publication-title: Int J Environ Res Public Health. – volume: 34 start-page: 154 issue: 1 year: 2019 end-page: 161 article-title: Altered uric acid metabolism in isolated colonic Crohn's disease but not ulcerative colitis publication-title: J Gastroenterol Hepatol – volume: 24 start-page: 37 issue: 1 year: 1997 end-page: 39 article-title: Nephrotic syndrome from 5‐ASA for ulcerative colitis? Complicated by carcinoma of the colon and sclerosing cholangitis publication-title: J Clin Gastroenterol – volume: 40 start-page: 761 issue: 6 year: 1997 end-page: 766 article-title: Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylate publication-title: Gut – volume: 67 start-page: 481 issue: 4 year: 1994 end-page: 482 article-title: Interstitial nephritis associated with 5‐aminosalicylic acid publication-title: Nephron – volume: 115 start-page: 1033 issue: 8 year: 2015 end-page: 1041 article-title: Trends in management and outcomes of ST‐elevation myocardial infarction in patients with end‐stage renal disease in the United States publication-title: Am J Cardiol – volume: 18 start-page: 2262 issue: 10 year: 2020 end-page: 2268 article-title: Inflammatory bowel diseases are associated with an increased risk for chronic kidney disease, which decreases with age publication-title: Clin Gastroenterol Hepatol – volume: 47 start-page: 585 issue: 4 year: 2020 end-page: 595 article-title: Chronic kidney disease publication-title: Prim Care – volume: 12 start-page: 720 issue: 12 year: 2015 end-page: 727 article-title: The global burden of IBD: from 2015 to 2025 publication-title: Nat Rev Gastroenterol Hepatol – volume: 296 start-page: 1442 issue: 6634 year: 1988 article-title: Nephrotic syndrome after treatment with 5‐aminosalicylic acid publication-title: Br Med J (Clin Res Ed) – volume: 10 start-page: 815 year: 2019 article-title: NFκB and kidney injury publication-title: Front Immunol – volume: 390 start-page: 2769 issue: 10114 year: 2017 end-page: 2778 article-title: Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population‐based studies publication-title: Lancet – volume: 33 year: 2023 article-title: Inflammatory bowel disease prevalence: surveillance data from the U.S publication-title: Prev Med Rep. – volume: 37 start-page: 337 issue: 8 year: 2016 end-page: 347 article-title: Inflammatory bowel disease publication-title: Pediatr Rev – volume: 22 start-page: 146 issue: 1 year: 2021 article-title: Different renal manifestations associated with very early onset pediatric inflammatory bowel disease: case report and review of literature publication-title: BMC Nephrol – volume: 20 start-page: 91 issue: 1 year: 2014 end-page: 99 article-title: Inflammatory bowel disease: pathogenesis publication-title: World J Gastroenterol – volume: 22 start-page: 6 issue: 1 year: 2015 end-page: 15 article-title: Socioeconomic disparities in chronic kidney disease publication-title: Adv Chronic Kidney Dis – volume: 38 start-page: 99 issue: 1 year: 1996 end-page: 103 article-title: Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease publication-title: Gut – volume: 89 start-page: 185 issue: 1 year: 2016 end-page: 192 article-title: Assessing the risk of incident hypertension and chronic kidney disease after exposure to shock wave lithotripsy and ureteroscopy publication-title: Kidney Int – volume: 15 start-page: 41 issue: 1 year: 2002 end-page: 52 article-title: The kidneys in inflammatory bowel disease publication-title: Ann Gastroenterol – volume: 24 start-page: 2 issue: Suppl 1 year: 2006 end-page: 9 article-title: Review article: mode of action and delivery of 5‐aminosalicylic acid – new evidence publication-title: Aliment Pharmacol Ther – volume: 63 start-page: 255 issue: 1 year: 2003 end-page: 265 article-title: Urine stone risk factors in nephrolithiasis patients with and without bowel disease publication-title: Kidney Int – volume: 1165 start-page: 3 year: 2019 end-page: 15 article-title: Prevalence and disease burden of chronic kidney disease publication-title: Adv Exp Med Biol – volume: 44 start-page: 1 issue: 1 year: 1999 end-page: 13 article-title: Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis publication-title: Dig Dis Sci – volume: 72 start-page: 529 issue: 4 year: 2021 end-page: 535 article-title: 5‐aminosalicylic acid inhibits the expression of oncomiRs and pro‐inflammatory microRNAs: an in vitro study publication-title: J Physiol Pharmacol – volume: 6 start-page: 264 issue: 3 year: 2017 end-page: 269 article-title: Nephrolithiasis as a common urinary system manifestation of inflammatory bowel diseases; a clinical review and meta‐analysis publication-title: J Nephropathol – volume: 9 start-page: 265 issue: 2 year: 2014 end-page: 270 article-title: The histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease publication-title: Clin J Am Soc Nephrol – volume: 14 start-page: 573 issue: 10 year: 2017 end-page: 584 article-title: Gut microbiota and IBD: causation or correlation? publication-title: Nat Rev Gastroenterol Hepatol – volume: 12 start-page: 113 issue: 2 year: 2019 end-page: 122 article-title: A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease publication-title: J Med Life – volume: 27 start-page: 61 issue: 1 year: 2022 article-title: 5‐ASA induced interstitial nephritis in patients with inflammatory bowel disease: a systematic review publication-title: Eur J Med Res – volume: 16 start-page: 38 issue: 1 year: 2020 end-page: 51 article-title: New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD publication-title: Autophagy – volume: 10 issue: 1 year: 2015 article-title: The restrained expression of NF‐kB in renal tissue ameliorates folic acid induced acute kidney injury in mice publication-title: PLoS One – volume: 11 issue: 7 year: 2016 article-title: Global prevalence of chronic kidney disease – a systematic review and meta‐analysis publication-title: PLoS One – volume: 22 start-page: 2902 issue: 12 year: 2016 end-page: 2906 article-title: Crohn's disease is associated with the risk for thyroid cancer publication-title: Inflamm Bowel Dis – volume: 9 start-page: 206 year: 2019 article-title: Alterations to the gut microbiota and their correlation with inflammatory factors in chronic kidney disease publication-title: Front Cell Infect Microbiol – volume: 66 start-page: s03 issue: Suppl 1 year: 2020 end-page: s09 article-title: Chronic kidney disease publication-title: Rev Assoc Med Bras (1992) – volume: 107 start-page: 103 issue: 1 year: 1994 end-page: 108 article-title: A shared and unique peptide in the human colon, eye, and joint detected by a monoclonal antibody publication-title: Gastroenterology – volume: 71 start-page: 261 issue: 5 year: 1992 end-page: 270 article-title: Amyloidosis and inflammatory bowel disease. A 50‐year experience with 25 patients publication-title: Medicine (Baltimore) – volume: 12 start-page: 944 issue: 4 year: 2020 article-title: Nutrition, IBD and gut microbiota: a review publication-title: Nutrients – volume: 28 year: 2022 article-title: Renal manifestations in inflammatory bowel disease: a cohort study during the biologic era publication-title: Med Sci Monit – volume: 14 start-page: 442 issue: 7 year: 2018 end-page: 456 article-title: The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease publication-title: Nat Rev Nephrol – volume: 345 year: 2012 article-title: Kidney stones and kidney function loss: a cohort study publication-title: BMJ – volume: 33 start-page: 1006 issue: 7 year: 1992 end-page: 1007 article-title: Sulphasalazine induced renal failure publication-title: Gut – volume: 57 start-page: 619 issue: 9 year: 2022 end-page: 629 article-title: Renal manifestations in inflammatory bowel disease: a systematic review publication-title: J Gastroenterol – volume: 23 start-page: 481 issue: 4 year: 2022 end-page: 497 article-title: Cutaneous manifestations of inflammatory bowel disease: a basic overview publication-title: Am J Clin Dermatol – volume: 37 start-page: 9 issue: 1 year: 2017 end-page: 19 article-title: Gut microbiota in chronic kidney disease publication-title: Nefrologia – volume: 3 start-page: 4 issue: 1 year: 2018 end-page: 11 article-title: Extraintestinal manifestations of inflammatory bowel disease: clinical aspects and pathogenesis publication-title: J Gastroenterol Dig Dis – volume: 53 start-page: 205 issue: 2 year: 2021 end-page: 209 article-title: Urolithiasis in complicated inflammatory bowel disease: a comprehensive analysis of urine profile and stone composition publication-title: Int Urol Nephrol – volume: 301 start-page: 818 issue: 6755 year: 1990 article-title: Nephrotic syndrome associated with sulphasalazine publication-title: BMJ – volume: 125 start-page: 297 issue: 8 year: 2005 end-page: 300 article-title: Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis publication-title: Med Clin (Barc) – volume: 10 start-page: 226 issue: 2 year: 2016 end-page: 235 article-title: Renal involvement in inflammatory bowel diseases publication-title: J Crohns Colitis – ident: e_1_2_9_3_1 doi: 10.3748/wjg.v20.i1.91 – ident: e_1_2_9_10_1 doi: 10.1371/journal.pone.0158765 – ident: e_1_2_9_32_1 doi: 10.1159/000188024 – ident: e_1_2_9_11_1 doi: 10.1007/978-981-13-8871-2_1 – ident: e_1_2_9_49_1 doi: 10.1093/ecco-jcc/jjv138 – ident: e_1_2_9_39_1 doi: 10.1016/j.cgh.2019.10.043 – ident: e_1_2_9_46_1 doi: 10.3389/fimmu.2019.00815 – volume: 15 start-page: 41 issue: 1 year: 2002 ident: e_1_2_9_21_1 article-title: The kidneys in inflammatory bowel disease publication-title: Ann Gastroenterol – ident: e_1_2_9_12_1 doi: 10.1053/j.ackd.2014.07.002 – ident: e_1_2_9_9_1 doi: 10.1016/j.pop.2020.08.001 – ident: e_1_2_9_38_1 doi: 10.1016/0895-4356(93)90103-8 – volume: 72 start-page: 529 issue: 4 year: 2021 ident: e_1_2_9_43_1 article-title: 5‐aminosalicylic acid inhibits the expression of oncomiRs and pro‐inflammatory microRNAs: an in vitro study publication-title: J Physiol Pharmacol – ident: e_1_2_9_41_1 doi: 10.3748/wjg.v24.i42.4798 – volume: 3 start-page: 4 issue: 1 year: 2018 ident: e_1_2_9_54_1 article-title: Extraintestinal manifestations of inflammatory bowel disease: clinical aspects and pathogenesis publication-title: J Gastroenterol Dig Dis – ident: e_1_2_9_62_1 doi: 10.1080/15548627.2019.1635384 – ident: e_1_2_9_16_1 doi: 10.1136/bmj.301.6755.818-b – ident: e_1_2_9_20_1 doi: 10.1136/gut.40.6.761 – ident: e_1_2_9_2_1 doi: 10.1542/pir.2015-0110 – ident: e_1_2_9_5_1 doi: 10.1038/nrgastro.2015.150 – ident: e_1_2_9_25_1 doi: 10.2147/IJNRD.S45466 – ident: e_1_2_9_14_1 doi: 10.12659/MSM.936497 – ident: e_1_2_9_33_1 doi: 10.1093/gastro/gow015 – ident: e_1_2_9_26_1 doi: 10.1038/ki.2015.321 – ident: e_1_2_9_7_1 doi: 10.1016/j.pmedr.2023.102173 – volume: 8 start-page: 461 issue: 5 year: 1996 ident: e_1_2_9_29_1 article-title: Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease publication-title: Eur J Gastroenterol Hepatol – ident: e_1_2_9_4_1 doi: 10.25122/jml-2018-0075 – ident: e_1_2_9_61_1 doi: 10.1038/s41581-018-0018-2 – ident: e_1_2_9_63_1 doi: 10.3390/nu12040944 – ident: e_1_2_9_23_1 doi: 10.1007/s00535-022-01903-6 – ident: e_1_2_9_19_1 doi: 10.1136/bmj.296.6634.1442 – ident: e_1_2_9_48_1 doi: 10.1007/s40257-022-00689-w – ident: e_1_2_9_45_1 doi: 10.1371/journal.pone.0115947 – ident: e_1_2_9_47_1 doi: 10.1186/s12882‐021‐02358‐2 – ident: e_1_2_9_52_1 doi: 10.1023/A:1026629528233 – ident: e_1_2_9_30_1 doi: 10.1136/gut.38.1.99 – ident: e_1_2_9_42_1 doi: 10.1186/s40001‐022‐00687‐y – ident: e_1_2_9_24_1 doi: 10.1136/bmj.e5287 – ident: e_1_2_9_51_1 doi: 10.1016/0016-5085(94)90066-3 – ident: e_1_2_9_58_1 doi: 10.1111/jgh.14356 – ident: e_1_2_9_8_1 doi: 10.1590/1806-9282.66.s1.3 – ident: e_1_2_9_56_1 doi: 10.15171/jnp.2017.42 – ident: e_1_2_9_15_1 doi: 10.2215/CJN.04660513 – ident: e_1_2_9_27_1 doi: 10.1046/j.1523-1755.2003.00725.x – ident: e_1_2_9_6_1 doi: 10.1016/S0140-6736(17)32448-0 – ident: e_1_2_9_17_1 doi: 10.1136/gut.33.7.1006 – ident: e_1_2_9_59_1 doi: 10.1016/j.nefro.2016.05.008 – ident: e_1_2_9_64_1 doi: 10.1038/nrgastro.2017.88 – ident: e_1_2_9_35_1 doi: 10.1097/MIB.0000000000000963 – ident: e_1_2_9_13_1 doi: 10.1002/hsr2.1563 – ident: e_1_2_9_22_1 doi: 10.1093/ibd/izac140 – ident: e_1_2_9_28_1 doi: 10.1097/00005792-199209000-00001 – ident: e_1_2_9_36_1 doi: 10.1016/j.amjcard.2015.01.529 – ident: e_1_2_9_37_1 doi: 10.1001/jamacardio.2016.5131 – ident: e_1_2_9_53_1 doi: 10.1016/0016-5085(90)90839-S – ident: e_1_2_9_18_1 doi: 10.1097/00004836-199701000-00008 – volume: 125 start-page: 297 issue: 8 year: 2005 ident: e_1_2_9_50_1 article-title: Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis publication-title: Med Clin (Barc) – ident: e_1_2_9_60_1 doi: 10.3389/fcimb.2019.00206 – ident: e_1_2_9_40_1 doi: 10.1007/s10238-021-00766-0 – ident: e_1_2_9_55_1 doi: 10.1111/apt.15687 – ident: e_1_2_9_34_1 doi: 10.3390/ijerph19137933 – ident: e_1_2_9_44_1 doi: 10.1111/j.1365-2036.2006.03069.x – ident: e_1_2_9_57_1 doi: 10.1007/s11255-020-02649-x – ident: e_1_2_9_31_1 doi: 10.1136/gut.35.10.1493  | 
    
| SSID | ssj0056786 | 
    
| Score | 2.3464956 | 
    
| Snippet | Objectives
The incidence and prevalence of inflammatory bowel disease (IBD), mainly including ulcerative colitis (UC) and Crohn's disease (CD), are increasing... The incidence and prevalence of inflammatory bowel disease (IBD), mainly including ulcerative colitis (UC) and Crohn's disease (CD), are increasing globally.... ObjectivesThe incidence and prevalence of inflammatory bowel disease (IBD), mainly including ulcerative colitis (UC) and Crohn's disease (CD), are increasing...  | 
    
| SourceID | proquest pubmed crossref wiley  | 
    
| SourceType | Aggregation Database Index Database Enrichment Source Publisher  | 
    
| StartPage | 572 | 
    
| SubjectTerms | Adult chronic kidney diseases Colitis, Ulcerative - complications Crohn disease Crohn Disease - complications Crohn Disease - epidemiology Crohn's disease Humans Inflammatory bowel disease Inflammatory bowel diseases Inflammatory Bowel Diseases - complications Inpatients Intestine Kidney diseases Kidney stones Multivariate analysis Nephritis Nephritis, Interstitial - complications Nephritis, Interstitial - epidemiology Nephrolithiasis Nephrolithiasis - complications Nephrolithiasis - epidemiology Propensity Score Renal Insufficiency, Chronic - complications Renal Insufficiency, Chronic - etiology Retrospective Studies Ulcerative colitis  | 
    
| Title | Association between inflammatory bowel disease, nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease: A propensity score‐matched analysis of US nationwide inpatient sample 2016–2018 | 
    
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2F1751-2980.13233 https://www.ncbi.nlm.nih.gov/pubmed/37823607 https://www.proquest.com/docview/2902762722 https://www.proquest.com/docview/2876638931  | 
    
| Volume | 24 | 
    
| hasFullText | 1 | 
    
| inHoldings | 1 | 
    
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVEBS databaseName: Academic Search Ultimate (EBSCOhost) customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1751-2980 dateEnd: 20241102 omitProxy: true ssIdentifier: ssj0056786 issn: 1751-2972 databaseCode: ABDBF dateStart: 20070301 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 1751-2972 databaseCode: DR2 dateStart: 20000101 customDbUrl: isFulltext: true eissn: 1751-2980 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0056786 providerName: Wiley-Blackwell  | 
    
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NatwwEBYlh9BL_3-2TcsUeuhhvazlH8m9haQhBNJD24XejGRJdMnGDvGa0J7yCIW-Vx8iT5IZyTZJSimhl90FS2sZfaP5xjP6xNhbnskqrYSKimzuKM2YR4XjLuIG_ZnNdaW8HMPhx3x_kR58zYZqQtoLE_QhxhduZBl-vSYDV7q9YuTo9-KIF5KObuAJ6X3GSe6Dqk-jgFSGS7HfXxTaCt6L-1Atz43-1_3SH2TzOnf1zmfvPtPDsEPNydGsW-tZ9eOGouN_PdcDdq-nprAdsPSQ3bH1I7Z52CffH7PfV6YS-vouQIAipo59rh50c2ZX0Od8plBbRArV131bqnbZTmHd6W7VkELFKZUoIPRDG9JVmoKqDVRBqxeOlqa234e_eg_bcEJZg5oqSKAl6c2L8594V4ScwY5BWAUaB4vPEN5vni2NxdH1urHQKpJBBiQi-cX5L_yST9hi78OXnf2oPw4iqhIMpaMiMchFhcpVpjVGTco6gXwpcRhCxqlSzsosFdok3OS5LgouFHI_iaAQlbSWJ0_ZRt3U9jkDbaRJhbKFdFnqtJMmLvBD2UypBGnDhM0GMJRVr5VOR3asyiFmolkqaZZKP0sT9m7scBJkQv7edGtAV9mvFy1ennN0S4LzCXszXkZLp_SNqm3TYRtJj4v8Mp6wZwGV470SQQfXzwUO3GPrX4Mod3Z3_Y8Xt-3wkt3lyPPCdswttrE-7ewr5GVr_dqb3iVKdzBs | 
    
| linkProvider | Wiley-Blackwell | 
    
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwELagSMCF_5-FAkbiwGGz2rWT2OFWtVQLdHuArtRbZMe2WHVJqmajCk59BCTei4fokzBjJ9G2CCHEZbNS7MSRv7G_8Yw_E_KKJbKIC6GiLBk7DDOmUeaYi5iB-cymulBejmG2n07n8fvD5HBtL0zQh-gX3NAy_HiNBo4L0mtWDhPfJGKZxLMbGOdXybU4BW8FidHHXkIqgcHY7zAKhQVr5X0wm-fSAy7OTL_RzYvs1U8_u7dJ0TU8ZJ0cjZqVHhXfLmk6_t-X3SG3WnZKtwKc7pIrtrxHrs_a-Pt98nOtN2mb4kUBowCrLz5cT3V1ape0DfsMaWkBLJhi93mh6kU9pKtGN8sKRSpOMEsB0B_KoLTSkKrS0CLI9dKjhSnt1-5Rb-gWPcbAQYlJJLRG9c3zs-_wVkCdgYpBW4VWjs4_0bDEebowFlrXSsfSWqESMgUukp6f_YCLfEDmu28PtqdReyJEVHDwpqOMG6CjQqUq0RocJ2WdAMrEHXiRk1gpZ2USC204M2mqs4wJBfRP8pSLQlrL-EOyUValfUyoNtLEQtlMuiR22kkzyeBH2UQpDsxhQEYdGvKilUvHUzuWeec2YS_l2Eu576UBed1XOA5KIX8uutnBK2-HjBpujxnMTIKxAXnZ3wZjxwiOKm3VQBmJnwsUczIgjwIs-3dxgWfXjwU03IPrb43It3d2_J8n_1rhBbkxPZjt5Xvv9j88JTcZ0L6wO3OTbKxOGvsMaNpKP_d2-AtMLDSN | 
    
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwELagSBUXKH9loRQjceCwWe3aSexwq7pdlZ9WCFipt8iObbHqkqyajar21EdA4r36EH0SZuIk2hYhhLgkkWInjvyN53Nm_JmQ1yySWZgJFSTR0GGYMQ4Sx1zADPgzG-tM1XIMB4fx_jR8fxQdrayF8foQ3Q83tIx6vEYDtwvjVqwcHN8oYInEvRsY57fJnTBKJKb1jT93ElIRDMb1CiNfWLBG3gezeW484Lpn-o1uXmevtfuZ3CdZ23CfdXI8qJZ6kJ3f0HT8vy_bIPcadkp3PJwekFs2f0jWD5r4-yNyudKbtEnxooBRgNX3OlxPdXFq57QJ-_RpbgEsmGL3babKWdmny0pX8wJFKk4wSwHQ78ugtFKfqtzQzMv10uOZye1Z-6i3dIcuMHCQYxIJLVF98-riB7wVUGegotdWoYWj0y_U_-I8nRkLrWukY2mpUAmZAheJry5-wkk-JtPJ3tfd_aDZESLIOMymg4QboKNCxSrSGiZOyjoBlIk7mEWOQqWclVEotOHMxLFOEiYU0D_JYy4yaS3jT8haXuT2KaHaSBMKZRPpotBpJ80ogYOykVIcmEOPDFo0pFkjl467dszTdtqEvZRiL6V1L_XIm67CwiuF_LnoVguvtBkySrg9ZOCZBGM98qq7DcaOERyV26KCMhI_FyjmqEc2PSy7d3GBe9cPBTS8BtffGpHujsf1xbN_rfCSrH8aT9KP7w4_PCd3GbA-vzhzi6wtTyr7AljaUm_XZvgLq9g0EQ | 
    
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+inflammatory+bowel+disease%2C+nephrolithiasis%2C+tubulointerstitial+nephritis%2C+and+chronic+kidney+disease%3A+A+propensity+score%E2%80%90matched+analysis+of+US+nationwide+inpatient+sample+2016%E2%80%932018&rft.jtitle=Journal+of+digestive+diseases&rft.au=Wei+Wei+Zheng&rft.au=Zhou%2C+Quan&rft.au=Meng+Li+Xue&rft.au=Yu%2C+Xing&rft.date=2023-11-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=1751-2972&rft.eissn=1751-2980&rft.volume=24&rft.issue=11&rft.spage=572&rft.epage=583&rft_id=info:doi/10.1111%2F1751-2980.13233&rft.externalDBID=NO_FULL_TEXT | 
    
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1751-2972&client=summon | 
    
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1751-2972&client=summon | 
    
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1751-2972&client=summon |